Latest Medical Strategy News
Mar 4, 2021
March 04, 2021 08:00 AM Eastern Standard Time ENGLEWOOD CLIFFS, N.J.--( BUSINESS WIRE )-- W Medical Strategy Group , a healthcare consulting firm focused on cross-border business transactions, is hosting an upcoming virtual webinar for its New York Health Forum series on Tuesday, March 16, 2021. Details of the virtual panel are below: Title: Investing in Space – Next Frontier of Healthcare Date/Time: March 16, 2021, 12PM - 1PM EST Moderator: Kimberly Ha, CEO at KKH Advisors Panelists: Dr. Mark Ott, Microbiology Lead at Johnson Space Center at NASA Dr. Ji Sun Park, Senior Scientist at Enzychem Lifesciences “I look forward to discussions by thought leaders that lead the way to accelerate progress against space radiation and other space-related health threats in this virtual panel,” said DoHyun Cho, Ph.D., Chairman of New York Health Forum. “We are inspired by the industry’s efforts to move forward in space exploration. In this science forum, we hope to explore areas that are not frequently discussed, to support astronauts and space-related health and wellness during deep space missions. Complimentary registration is available to executives in the biotech and space industry, investors, media and academia via the registration link here . About W Medical Strategy Group W Medical Strategy Group (WMSG) is a cross-border healthcare consulting firm that uses deep industry expertise and to help companies achieve optimal business results. WMSG operates media and distribution divisions to provide enriched platforms to professionals in the healthcare industry. WMSG hosts the New York Health Forum (NYHF), where discussions on the latest trends and issues in healthcare take place. Moreover, WMSG has published and distributed the World Asian Medical Journal (WAMJ), a medical magazine that covers interviews of internationally recognized physicians and entrepreneurs of Asian background, for 23 issues to over 38,000 readers around the world. About New York Health Forum Since 2014, New York Health Forum (NYHF) remains committed to amplifying the life sciences industry’s efforts to develop solutions for patients and lead the discussions on disruptive innovation and continued progress. Contacts
Medical Strategy Team
2 Team Members
Medical Strategy has 2 team members, including current Managing Director, Juergen Harter.